Bacteriobots: Bacterial Microrobots and Their Potential in Cancer Diagnosis and Therapy

Article Sidebar

pdf (Русский)
Published: Mar 13, 2026
DOI: https://doi.org/10.18097/BMCRM00301
Keywords:
bacterial microrobot; bacteriobot; bacterial biohybrid; antitumor therapy

Main Article Content

L.N. Ikryannikova
Sechenov First Moscow State Medical University, 8/2 Trubetskaya str., Moscow, 119991 Russia

Abstract

Oncological diseases represents one of the most serious public health problem, claiming millions of lives each year. Routine cancer treatment still has significant limitations, due to side effects, unsufficient effectiveness in metastasis and recurrence, and high cost. Therefore, the development of new approaches for antitumor therapy is an important and priority task. Bacteria can be considered as a versatile and flexible natural biomaterial that has the property of moving independently and penetrating into hard-to-reach areas of the human body, delivering therapeutic agents directly to cancer cells. Also, bacteria demonstrate the natural immunogenicity, which allows them to attract immune cells into the tumor microenvironment (TME) and promote the effectiveness of the immune response. This is a reason why the seemingly fantastic idea of creating a bacteriobot, an autonomous microrobot based on a living bacterium for delivering therapeutic cargo, is becoming more and more popular. This review highlights the basic principles of designing bacterial microrobots, ways to their targeting to cancer cells and supplying with therapeutic agents, as well as the safety of bacteriobots for humans and the prospects for their use in the treatment of malignant neoplasms.

Article Details

How to Cite
Ikryannikova, L. (2026). Bacteriobots: Bacterial Microrobots and Their Potential in Cancer Diagnosis and Therapy. Biomedical Chemistry: Research and Methods, 9(1), e00301. https://doi.org/10.18097/BMCRM00301
Issue
Vol. 9 No. 1 (2026): Online first
Section
REVIEWS

References

  1. Alqarni, S.S., Khan, N.U. (2025) Integrating alternative therapies in overcoming chemotherapy resistance in tumors. Mol. Biol. Rep., 52(1), 239. DOI
  2. Park, S.J., Park, S-H., Cho, S., Kim, D-M., Lee, Y., Ko, S.Y., Hong, Y., Choy, H.E., Min, J-J., Park, J-O, Park, S. (2013) New paradigm for tumor theranostic methodology using bacteria-based microrobot. Sci. Rep., 3, 3394. DOI
  3. Park, D., Park, S.J., Cho, S., Lee, Y., Lee, Y.K., Min, J-J., Park, B.J., Ko, S.Y., Park, J-O., Park, S. (2014) Motility analysis of bacteria-based microrobot (bacteriobot) using chemical gradient microchamber. Biotechnol. Bioeng., 111, 134–143. DOI
  4. Schmidt, C.K., Medina-Sánchez, M., Edmondson, R.J., Schmidt, O.G. (2020) Engineering microrobots for targeted cancer therapies from a medical perspective. Nat. Commun., 11(1), 5618. DOI
  5. Alizadeh, S., Esmaeili, A., Barzegari, A., Rafi, M.A., Omidi, Y. (2020) Bioengineered smart bacterial carriers for combinational targeted therapy of solid tumors. J. Drug Target., 28(7-8), 700-713. DOI
  6. Chen, Y., Li, Z.-H., Zeng, X., Zhang, X.-Z. (2023) Bacteria-based bioactive materials for cancer imaging and therapy. Adv. Drug Delivery Rev., 193, 114696. DOI
  7. Chen, H., Li, Y., Li, Z., Sun, Y., Gu, W., Chen, C., Cheng, Y. (2025) Bacterial autonomous intelligent microrobots for biomedical applications. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 17(2), e70011. DOI
  8. Chen, J., Chen, J., Chen, Y., Yuan, W., Zhang, J., Wang, G., Dai, Z. (2025) Engineering bacteria as living therapeutics in cancer therapy. Adv. Sci. (Weinh), 28, e07820. DOI
  9. Zhou, S., Gravekamp, C., Bermudes, D., Liu, K. (2018) Tumor-targeting bacteria engineered to fight cancer. Nat. Rev. Cancer, 18(12), 727–743. DOI
  10. Lin, X., Jiao, R., Cui, H., Yan, X., Zhang, K. (2024) Physiochemically and genetically engineered bacteria: instructive design principles and diverse applications. Adv. Sci. (Weinh), 11(30), e2403156. DOI
  11. Riglar, D.T., Silver, P.A. (2018) Engineering bacteria for diagnostic and therapeutic applications. Nat. Rev. Microbiol., 16, 214–225. DOI
  12. Lim, D., Song, M. (2019) Development of bacteria as diagnostics and therapeutics by genetic engineering. J. Microbiol., 57(8), 637-643. DOI
  13. Felgner, S., Kocijancic, D., Frahm, M., Weiss, S. (2016) Bacteria in cancer therapy: renaissance of an old concept. Int. J. Microbiol., 2016, 1-14. DOI
  14. Kucerova, P., Cervinkova, M. (2016) Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment. Anti-Cancer Drugs, 27(4), 269-277. DOI
  15. Challis, G.B., Stam, H.J. (1990) The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta Oncol., 29(5), 545-550. DOI
  16. Dróżdż, M., Makuch, S., Cieniuch, G., Woźniak, M., Ziółkowski, P. (2020) Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications. Life Sci., 261, 118296. DOI
  17. Sawant, S.S., Patil, S.M., Gupta, V., Kunda, N.K. (2020) Microbes as medicines: harnessing the power of bacteria in advancing cancer treatment. Int. J. Mol. Sci., 21, 7575. DOI
  18. Rubtsov, B.V. (2015) Bacteriological examination of malignant tumors (retrospective overview). I.P. Pavlov Rus. Med.-Biol. Vestn. 23(1), 155-167. DOI
  19. Burke, J. (2008) Cancer and infection. Aust. J. Med. Med. Herbalism, 20(2), 47-55.
  20. Robertson, W.F. (1921) The relation of carcinoma to infection. Br. Med. J., 2, 929. DOI
  21. Wainwright, M., Al Talih, A. (2003) Is this the historical ‘cancer germ’ Med. Hypotheses., 60, 290-292. DOI
  22. Nauts, H.C., McLaren, J.R. (1990) Coley toxins—the first century. Adv. Exp. Med. Biol., 267, 483-500. DOI
  23. Wiemann, B., Starnes, C.O. (1994) Coley’s toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol. Ther., 64, 529-564. DOI
  24. Bickels, J., Kollender, Y., Merinsky, O., Meller, I. (2002) Coley’s toxin: historical perspective. Isr. Med. Assoc. J., 4(6), 471-472.
  25. Ikryannikova, L.N., Gorokhovets, N.V., Belykh, D.A., Kurbatov, L.K., Zamyatnin, A.A. (2023) Bacterial therapy of cancer: a way to the dustbin of history or to the medicine of the future? Int. J. Mol. Sci., 24, 9726. DOI
  26. Nybo, K. (2018) Part I: fighting cancer with deadly bacteria. BioTech., 64, 6-8. DOI
  27. Alipour, M. (2021) Molecular mechanism of Helicobacter pylori-induced gastric cancer. J. Gastrointest. Cancer., 52, 23-30. DOI
  28. Cummins, J., Tangney, M. (2013) Bacteria and tumours: causative agents or opportunistic inhabitants? Infect. Agents Cancer, 8, 11. DOI
  29. Al-Hilu, S.A., Al-Shujairi, W.H. (2020) Dual role of bacteria in carcinoma: stimulation and inhibition. Int. J. Microbiol., 2020, 1-15. DOI
  30. Song, S., Vuai, M.S., Zhong, M. (2018) The role of bacteria in cancer therapy–enemies in the past, but allies at present. Infectious agents and cancer, 13, 1-7. DOI
  31. Pan, W., Liu, H., Wu, D. (2025) Advances in engineered bacteria for cancer therapy. Precision Medicine and Engineering, 2, 100017. DOI
  32. Feng, Z., Wang, Y., Xu, H., Guo, Y., Xia, W., Zhao, C., Zhao, X., Wu, J. (2023) Recent advances in bacterial therapeutics based on sense and response. Acta Pharmaceutica Sinica B, 13(3), 1014e1027. DOI
  33. Felgner, S., Pawar, V., Kocijancic, D., Erhardt, M., Weiss, S. (2017) Tumourtargeting bacteria-based cancer therapies for increased specificity and improved outcome. Microbial. Biotechnology, 10(5), 1074–1078. DOI
  34. Nallar, S.C., Xu, D-Q., Kalvakolanu, D.V. (2017) Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challenges. Cytokine, 89, 160–172. DOI
  35. Zu, C., Wang, J. (2013) Tumor-colonizing bacteria: A potential tumor targeting therapy. Crit. Rev. Microbiol., 40(3), 225-35. DOI
  36. Zottel, A., Paska, A.V., Jovčevska, I. (2019) Nanotechnology meets oncology: nanomaterials in brain cancer research, diagnosis and therapy, Materials (Basel), 12, 1588. DOI
  37. Cho, S., Choi, Y.J., Zheng, S., Han, J., Ko, S.Y., Park, J-O., Park, S. (2015) Modeling of chemotactic steering of bacteria-based microrobot using a population-scale approach. Biomicrofluidics, 9(5), 054116. DOI
  38. Chen, Q.-W., Qiao, J.-Y., Liu, X.-H., Zhang, C., Zhang, X.-Z. (2021) Customized materials-assisted microorganisms in tumor therapeutics, Chem. Soc. Rev., 50, 12576–12615.
  39. Pan, H., Zheng, M., Ma, A., Liu, L., Cai, L. (2021) Cell/bacteria-based bioactive materials for cancer immune modulation and precision therapy. Adv. Mater., 33(50), e2100241. DOI
  40. Chen, Y., Du, M., Yu, J., Rao, L., Chen, X., Chen, Z. (2020) Nanobiohybrids: a synergistic integration of bacteria and nanomaterials in cancer therapy. BIO Integration, 1(1), 25–36. DOI
  41. Forbes, N.S. (2010) Engineering the perfect (bacterial) cancer therapy. Nat. Rev. Cancer, 10(11), 785–794. DOI
  42. Chien, T., Doshi, A., Danino, T. (2017) Advances in bacterial cancer therapies using synthetic biology. Curr. Opin. Syst. Biol., 5, 1–8. DOI
  43. Sieow, B.F. L., Wun, K.S., Yong, W.P., Hwang, I.Y., Chang, M.W. (2021) Tweak to treat: reprograming bacteria for cancer treatment. Trends Cancer, 7, 447-464. DOI
  44. Liang, K., Liu, Q., Kong, Q. (2021) New technologies in developing recombinant‐attenuated bacteria for cancer therapy. Biotechnol. Bioeng., 118(2), 513-530. DOI
  45. Piñero-Lambea, C., Bodelón, G., Fernández-Periáñez, R., Cuesta, A.M., Álvarez-Vallina, L., Ángel Fernández, L. (2015) Programming controlled adhesion of E. coli to target surfaces, cells, and tumors with synthetic adhesins. ACS Synth. Biol., 4(4), 463–473, DOI
  46. Ho, C.L., Tan, H.Q., Chua, K.J., Kang, A., Lim, K.H., Ling, K.L., Yew, W.S., Lee, Y.S., Thiery, J.P., Chang, M.W. (2018). Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention. Nature Biomedical Engineering, 2(1), 27–37. DOI
  47. Nguyen, D.H., Chong, A., Hong, Y., Min, J.J. (2023) Bioengineering of bacteria for cancer immunotherapy. Nat. Commun., 14, 3553. DOI
  48. Loeffler, M., Le’Negrate, G., Krajewska, M., Reed, J.C. (2008) Inhibition of tumor growth using salmonella expressing fas ligand. J. Nat. Cancer Inst., 100, 1113-1116. DOI
  49. Taherkhani, S., Mohammadi, M., Daoud, J., Martel, S., Tabrizian, M. (2014) Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents. ACS Nano, 8, 5049–5060. DOI
  50. Nguyen, V.D., Han, J.-W., Choi, Y.J., Cho, S., Zheng, S., Ko, S.Y., Park, J.- O., Park, S. (2016) Active tumor-therapeutic liposomal bacteriobot combining a drug (paclitaxel)-encapsulated liposome with targeting bacteria (Salmonella typhimurium). Sensors Actuators B Chem., 224, 217–224, DOI
  51. Pan, P., Fan, J.-X., Wang, X.-N., Wang, J.-W., Zheng, D.-W., Cheng, H., Zhang, X.-Z. (2019) Bio-orthogonal bacterial reactor for remission of heavy metal poisoning and ROS elimination. Adv. Sci., 6(24), 1902500. DOI
  52. Bazylinski, D.A., Williams, T.J., Lefèvre, C.T., Berg, R.J., Zhang, C.L., Bowser, S.S., Dean, A.J., Beveridge, T.J. (2013) Magnetococcus marinus gen. nov., sp. nov., a marine, magnetotactic bacterium that represents a novel lineage (Magnetococcaceae fam. nov., Magnetococcales ord. nov.) at the base of the Alphaproteobacteria. Int. J. Syst. Evol. Microbiol., 63(3), 801-808. DOI
  53. Yan, S., Zeng, X., Wang, Y., Liu, B.-F. (2020) Biomineralization of bacteria by a metal-organic framework for therapeutic delivery. Adv. Healthc. Mater., 9(12), e2000046. DOI
  54. Anselmo, A.C., McHugh, K.J., Webster, J., Langer, R., Jaklenec, A. (2016) Layer-by-layer encapsulation of probiotics for delivery to the microbiome. Adv. Mater., 28(43), 9486-9490. DOI
  55. Chen, H., Li, Y., Wang, Y., Ning, P., Shen, Y., Wei, X., Feng, Q., Liu, Y., Li, Z., Xu, C., Huang, S., Deng, C., Wang, P., Cheng, Y. (2022) An engineered bacteriahybrid microrobot with the magnetothermal bioswitch for remotely collective perception and imaging-guided cancer treatment. ACS Nano, 16(4), 6118-6133. DOI
  56. Pan, P., Dong, X., Chen, Y., Zeng, X., Zhang, X.Z. (2022) Engineered bacteria for enhanced radiotherapy against breast carcinoma. ACS Nano, 16(1), 801-812. DOI
  57. Akolpoglu, M.B., Alapan, Y., Dogan, N.O., Baltaci, S.F., Yasa, O., Aybar Tural, G., Sitti, M. (2022) Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli-responsive cargo delivery. Sci. Adv., 8(28), eabo6163. DOI
  58. Ma, X., Liang, X., Li, Y., Feng, Q., Cheng, K., Ma, N., Zhu, F., Guo, X., Yue, Y., Liu, G., Zhang, T. (2023) Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field. Nat. Commun., 14(1), 1606. DOI
  59. Wang, W., Liu, X., Zheng, X., Jin, H.J., Li, X. (2020) Biomineralization: an opportunity and challenge of nanoparticle drug delivery systems for cancer therapy, Adv. Healthc. Mater., 9(22), 2001117. DOI
  60. Prozorov, T., Bazylinski, D.A., Mallapragada, S.K., Prozorov, R. (2013) Novel magnetic nanomaterials inspired by magnetotactic bacteria: topical review. Mater. Sci. Eng. R, 74(5), 133-172. DOI
  61. Wang, L., Qin, W., Xu, W., Huang, F., Xie, X., Wang, F., Ma, L., Zhang, C. (2021) Bacteria-mediated tumor therapy via photothermally-programmed cytolysin A expression, Small. 17(40), e2102932. DOI
  62. Chen, Q.W., Liu, X.H., Fan, J.X., Peng, S.Y., Wang, J.W., Wang, X.N., Zhang, C., Liu, C.J., Zhang, X. Z. (2020) Self–mineralized photothermal bacteria hybridizing with mitochondria–targeted metal–organic frameworks for augmenting photothermal tumor therapy. Adv. Funct. Mater., 30(14), 1909806. DOI
  63. Caudill, E.R., Hernandez, R.T., Johnson, K.P., O’Rourke, J.T., Zhu, L., Haynes, C.L., Feng, Z.V., Pedersen, J.A. (2020) Wall teichoic acids govern cationic gold nanoparticle interaction with Gram-positive bacterial cell walls. Chem. Sci., 11(16), 4106-4118. DOI
  64. Le, T.N., Tran, T.D., Kim, M.I. (2020) A convenient colorimetric bacteria detection method utilizing chitosan-coated magnetic nanoparticles. Nanomaterials, 10(1), 92. DOI
  65. Zheng, D.-W., Chen, Y., Li, Z.-H., Xu, L., Li, C.-X., Li, B., Fan, J.-X., Cheng, S.-X., Zhang, X.-Z. (2018) Optically-controlled bacterial metabolite for cancer therapy. Nat. Commun., 9(1), 1680. DOI
  66. Ding, S., Liu, Z., Huang, C., Zeng, N., Jiang, W., Li, Q. (2021) Novel engineered bacterium/black phosphorus quantum dot hybrid system for hypoxic tumor targeting and efficient photodynamic therapy. ACS Appl. Mater Interfaces, 13(8), 10564-10573. DOI
  67. Yang, Y., Hu, T., Bian, Y., Meng, F., Yu, S., Li, H., Zhang, Q., Gu, L., Weng, X., Tan, C., Liang, R. (2023) Coupling probiotics with 2D CoCuMo-LDH nanosheets as a tumor-microenvironment-responsive platform for precise NIRII photodynamic therapy. Adv. Mater., 35(23), e2211205. DOI
  68. Bae, Y.H., Park, K. (2011) Targeted drug delivery to tumors: myths, reality and possibility. J. Control Release, 153(3), 198-205. DOI
  69. Traore, M.A., Sahari, A., Behkam, B. (2018) Construction of Bacteria-Based Cargo Carriers for Targeted Cancer Therapy. Methods Mol. Biol., 1831, 25-35. DOI
  70. Bastos-Arrieta, J., Revilla-Guarinos, A., Uspal, W.E., Simmchen, J. (2018) Bacterial biohybrid microswimmers. Front. Robot. AI, 5, 97. DOI
  71. Pinero-Lambea, C., Ruano-Gallego, D., Fernandez, L.A. (2015). Engineered bacteria as therapeutic agents. Curr. Opin. Biotechnol., 35, 94-102. DOI
  72. Pawelek, J.M., Low, K.B., Bermudes, D. (1997) Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res., 57(20), 4537–4544
  73. Liang, S., Wang, C., Shao, Y., Wang, Y., Xing, D., Geng, Z. (2022) Recent advances in bacteria-mediated cancer therapy. Front. Bioeng. Biotechnol., 10, 1026248. DOI
  74. Zoaby, N., Shainsky-Roitman, J., Badarneh, S., Abumanhal, H., Leshansky, A., Yaron, S., Schroeder, A. (2016) Autonomous bacterial nanoswimmers target cancer. J. Control. Release, 257, 68–75. DOI
  75. Suh, S.B., Jo, A., Traore, M.A., Zhan, Y., Coutermarsh-Ott, S.L., Ringel-Scaia, V.M., Allen, I.C., Davis, R.M., Behkam, B. (2019) Nanoscale bacteria-enabled autonomous drug delivery system (NanoBEADS) enhances intratumoral transport of nanomedicine. Adv. Sci., 6, 1801309. DOI
  76. Alphandéry, E. (2020) Applications of magnetotactic bacteria and magnetosome for cancer treatment: A review emphasizing on practical and mechanistic aspects. Drug Discovery Today, 25(8), 1444-1452. DOI
  77. Mathuriya, A.S. (2015) Magnetotactic bacteria for cancer therapy. Biotechnol. Lett. 37, 491–498. DOI
  78. Felfoul, O., Mohammadi, M., Taherkhani, S., de Lanauze, D., Zhong, X.Y., Loghin, D., Essa, S., Jancik, S., Houle, D., Lafleur, M., Gaboury, L., Tabrizian, M., Kaou, N., Atkin, M., Vuong, T., Batist, G., Beauchemin, N., Radzioch, D., Martel, S. (2016) Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions. Nat. Nanotechnol., 11(11), 941 – 947. DOI
  79. Aubry, M., Wang, W.A., Guyodo, Y., Delacou, E., Guigner, J.M., Espeli, O., Lebreton, A., Guyot, F., Gueroui, Z. (2020) Engineering E. coli for magnetic control and the spatial localization of functions. ACS Synth. Biol., 9(11), 3030- 3041. DOI
  80. Li, D., Choi, H., Cho, S., Jeong, S., Jin, Z., Lee, C., Ko, S.Y., Park, J.O., Park, S. (2015) A hybrid actuated microrobot using an electromagnetic field and flagellated bacteria for tumor-targeting therapy. Biotechnol. Bioeng., 112(8), 1623-31. DOI
  81. Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., Fu, L. (2023) Neoantigens: promising targets for cancer therapy. Signal Transduct Target Ther., 8(1), 9. DOI
  82. Park, S-H., Zheng, J.H., Nguyen, V.H., Jiang, S-N., Kim, D-Y., Szardenings, M., Min, J.H., Hong, Y., Choy, H.E., Min, J-J. (2016) RGD peptide cellsurface display enhances the targeting and therapeutic efficacy of attenuated Salmonella-mediated cancer therapy. Theranostics, 6(10), 1672-1682. DOI
  83. Massa, P.E., Paniccia, A., Monegal, A., De Marco, A., Rescigno, M. (2013) Salmonella engineered to express CD20-targeting antibodies and a drugconverting enzyme can eradicate human lymphomas. J. Am. Soc. Hematol., 122, 705–714. DOI
  84. Al-Fandi, M., Alshraiedeh, N., Oweis, R., Alshdaifat, H., Al-Mahaseneh, O., Al-Tall, K., Alawneh, R. (2017) Novel selective detection method of tumor angiogenesis factors using living nano-robots. Sensors, 17(7), 1580. DOI
  85. Murakami, T., Hiroshima, Y., Miyake, K., Kiyuna, T., Endo, I., Zhao, M., Hoffman, R.M. (2019) Efficacy of tumor-targeting Salmonella typhimurium A1-R against malignancies in patient-derived orthotopic xenograft (PDOX) murine models. Cells, 8(6), 599. DOI
  86. Huh, J.H., Kittleson, J.T., Arkin, A.P., Anderson, J.C. (2013) Modular design of a synthetic payload delivery device. ACS Synth. Biol., 2, 418–424. DOI
  87. Ahmed, O.B., Lage, H. (2019) Bacteria-mediated delivery of RNAi effector molecules against viral HPV16-E7 eradicates oral squamous carcinoma cells (OSCC) via apoptosis. Cancer Gene Therapy, 26, 166–173 DOI
  88. Zhou, Y., Li, Q., Wu, Y., Zhang, W., Ding, L., Ji, C., Li, P., Chen, T., Feng, L., Tang, B.Z., Huang, X. (2024) Synergistic brilliance: engineered bacteria and nanomedicine unite in cancer therapy. Adv. Mater., 36(21), e2313953. DOI
  89. Wei, X., Du, M., Chen, Z., Yuan, Z. (2022) Recent advances in bacteria-based cancer treatment. Cancers, 14, 4945. DOI
  90. Yarahmadi, A., Zare, M., Aghayari, M., Afkhami, H., Jafari, G.A. (2024) Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future. Cell Commun. Signal., 22(1), 239. DOI
  91. Xia, X., Zhang, J.W., Zhao, B., Zhang, M., Chen, Z.R., Zhang, B.F., Ji, Y.L., Wang, X., Xiong, W.M., Li, J.W., Lv, Q.L. (2024) Progress of engineered bacteria for tumour therapy. Int. Immunopharmacol., 10(132), 111935. DOI
  92. Park, S.J., Lee, Y.K., Cho, S., Uthaman, S., Park, I.K., Min, J.J., Ko, S.Y., Park, J.O., Park, S. (2015) Effect of chitosan coating on a bacteria-based alginate microrobot. Biotechnol. Bioeng., 112(4), 769–776. DOI
  93. Chen, W., Wang, Y., Qin, M., Zhang, X., Zhang, Z., Sun, X., Gu, Z. (2018) Bacteria-driven hypoxia targeting for combined biotherapy and photothermal therapy. ACS Nano, 12(6), 5995–6005. DOI
  94. Cao, Z., Wang, X., Pang, Y., Cheng, S., Liu, J. (2019) Biointerfacial selfassembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment. Nature Communications, 10(1), 5783. DOI
  95. Hu, Q., Wu, M., Fang, C., Cheng, C., Zhao, M., Fang, W., Chu, P.K., Ping, Y., Tang, G. (2015) Engineering nanoparticle-coated bacteria as oral DNA vaccines for cancer immunotherapy. Nano Letters, 15(4), 2732–2739. DOI
  96. Harimoto, T., Hahn1, J., Chen, Y-Y., Im, J., Zhang, J., Hou, N., Li, F., Coker, C., Gray, K., Harr, N., Chowdhury, S., Pu, K., Nimura, C., Arpaia, N., Leong, K.W., Danino, T. (2022) A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat. Biotechnol., 40(8), 1259-1269. DOI
  97. Zhou, M., Tang, Y., Xu, W., Hao, X., Li, Y., Huang, S., Xiang, D., Wu, J. (2023) Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies. Front. Immunol., 14, 1140463. DOI
  98. Gurbatri, C.R., Arpaia, N., Danino, T. (2022) Engineering bacteria as interactive cancer therapies. Science, 378(6622), 858-864. DOI
  99. Huang, X., Pan, J., Xu, F., Shao, B., Wang, Y., Guo, X., Zhou, S. (2021) Bacteria-based cancer immunotherapy. Adv. Sci. (Weinh), 8(7), 2003572. DOI
  100. Leventhal, D.S., Sokolovska, A., Li, N., Plescia, C., Kolodziej, S.A., Gallant, C.W., Christmas, R., Gao, J-R., James, M.J., Abin-Fuentes, A., Momin, M., Bergeron, C., Fisher, A., Miller, P.F., West, K.A., Lora, J.M. (2020) Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. Nat. Commun., 11(1), 2739. DOI
  101. Divyashree, M., Prakash, S.K., Aditya, V., Aljabali, A.A., Alzahrani, K.J., Azevedo, V., Góes-Neto, A., Tambuwala, M.M., Barh, D. (2022) Bugs as drugs: neglected but a promising future therapeutic strategy in cancer. Future Oncol., 18(13), 1609-1626. DOI
  102. Rommasi, F. (2022) Bacterial-based methods for cancer treatment: what we know and where we are. Oncol. Ther., 10(1), 23-54. DOI
  103. Jia, H., Wei, P., Zhou, S., Hu, Y., Zhang, C., Liang, L., Li, B., Gan, Z., Xia, Y., Jiang, H., Shao, M., Guo, S., Yang, Z., Zhong, J., Ren, F., Zhang, H., Zhang, Y., Zhao, T. (2023) Attenuated Salmonella carrying siRNA-PD-L1 and radiation combinatorial therapy induces tumor regression on HCC through T cell-mediated immuno-enhancement. Cell Death Discov., 9, 318. DOI
  104. Arboleda-García, A., Alarcon-Ruiz, I., Boada-Acosta, L., Boada, Y., Vignoni, A., Jantus-Lewintre, E. (2023) Advancements in synthetic biologybased bacterial cancer therapy: A modular design approach. Crit. Rev. Oncol. Hematol., 190, 104088. DOI
  105. Cao, Z., Liu, J. (2020) Bacteria and bacterial derivatives as drug carriers for cancer therapy. J. Control. Release, 326, 396–407. DOI
  106. Mayakrishnan, V., Kannappan, P., Tharmalingam, N., Bose, R.J.C., Madheswaran, T., Ramasamy, M. (2022) Bacterial cancer therapy: A turning point for new paradigms. Drug Discov. Today, 27(8), 2043-2050. DOI
  107. Lu, Y., Mei, N., Ying, Y., Wang, D., Li, X., Zhao, Y., Zhu, Y., Shen, S., Yin, B. (2024) Bacteria-based nanoprobes for cancer therapy. Int. J. Nanomedicine, 19, 759-785. DOI
  108. Lou, X., Chen, Z., He, Z., Sun, M., Sun, J. (2021) Bacteria-mediated synergistic cancer therapy: small microbiome has a big hope. Nanomicro Lett., 13(1), 37. DOI
  109. Wang, M., Song, X., Liu, X., Ma, C., Ma, J., Shi, L. (2024) Engineered oncolytic bacteria for malignant solid tumor treatment. Interdiscip. Med., 2, e20240005. DOI
  110. Wang, J.W., Chen, Q.W., Luo, G.F., Han, Z.Y., Song, W.F., Yang, J., Chen, W.H., Zhang, X.Z. (2021) A self-driven bioreactor based on bacterium-metalorganic framework biohybrids for boosting chemotherapy via cyclic lactate catabolism. ACS Nano, 15(11), 17870-17884. DOI
  111. Ijaz, M., Khurshid, M., Gu, J., Hasan, I., Roy, S., Ullah, Z., Liang, S., Cheng, J., Zhang, Y., Mi, C., Guo, B. (2024) Breaking barriers in cancer treatment: nanobiohybrids empowered by modified bacteria and vesicles. Nanoscale, 16(18), 8759-8777. DOI
  112. Shuwen, H., Yifei, S., Xinyue, W., Zhanbo, Q., Xiang, Y., Xi, Y. (2024) Advances in bacteria-based drug delivery systems for anti-tumor therapy. Clin. Transl. Immunology, 13(7), e1518. DOI
  113. Liu, Y., Niu, L., Li, N., Wang, Y., Liu, M., Su, X., Bao, X., Yin, B., Shen, S. (2023) Bacterial-mediated tumor therapy: old treatment in a new context. Adv. Sci. (Weinh), 10(12), e2205641. DOI
  114. Fan, J.X., Niu, M.T., Qin, Y.T., Sun, Y.X., Zhang, X.Z. (2022) Progress of engineered bacteria for tumor therapy. Adv. Drug Deliv. Rev., 185, 114296. DOI
  115. Ye, Z., Liang, L., Lu, H., Shen, Y., Zhou, W., Li, Y. (2021) Nanotechnologyemployed bacteria-based delivery strategy for enhanced anticancer therapy. Int. J. Nanomedicine, 16, 8069-8086. DOI
  116. Brooks, S.M., Alper, H.S. (2021) Applications, challenges, and needs for employing synthetic biology beyond the lab. Nat. Commun., 12(1), 1390. DOI
  117. Chan, C.T., Lee, J.W., Cameron, D.E., Bashor, C.J., Collins, J.J. (2016) ‘Deadman’ and ‘Passcode’ microbial kill switches for bacterial containment. Nat. Chem. Biol., 12(2), 82-6. DOI
  118. Craig Venter, J., Glass, J.I., Hutchison, C.A., Vashee, S. (2022) Synthetic chromosomes, genomes, viruses, and cells. Cell, 185(15), 2708-2724. DOI
  119. Ali, M.K., Liu, Q., Liang, K., Li, P., Kong, Q. (2020) Bacteria-derived minicells for cancer therapy. Cancer Lett., 491, 11–21. DOI
  120. Park, S.Y. (2023) Chemically induced bacterial ghosts: a novel approach for advancing biomedical applications. Mol. Cell. Toxicol., 19, 657–665. DOI
  121. Li, D., Zhu, L., Wang, Y., Zhou, X., Li, Y. (2023) Bacterial outer membrane vesicles in cancer: biogenesis, pathogenesis, and clinical application. Biomed. Pharmacother., 165, 115120. DOI
  122. Weerakkody, L.R., Witharana, C. (2019) The role of bacterial toxins and spores in cancer therapy. Life Sci., 15(235), 116839. DOI
  123. Kuzajewska, D., Wszołek, A., Żwierełło, W., Kirczuk, L., Maruszewska, A. (2020) Magnetotactic bacteria and magnetosomes as smart drug delivery systems: a new weapon on the battlefield with cancer? Biology (Basel), 9(5), 102. DOI
  124. Zhang, Y., Ji, W., He, L., Chen, Y., Ding, X., Sun, Y., Hu, S., Yang, H., Huang, W., Zhang, Y., Liu, F., Xia, L. (2018) E. coli Nissle 1917-derived minicells for targeted delivery of chemotherapeutic drug to hypoxic regions for cancer therapy. Theranostics, 8(6), 1690-1705. DOI
  125. Ma, Y., Zhu, G., Feng, L., Jiang, S., Xiang, Q., Wang, J. (2023) Efficient cytotoxicity of recombinant azurin in Escherichia coli Nissle 1917-derived minicells against colon cancer cells. Bioengineering (Basel), 10(10), 1188. DOI
  126. Tang, S., Tang, D., Zhou, H., Li, Y., Zhou, D., Peng, X., Ren, C., Su, Y., Zhang, S., Zheng, H., Wan, F., Yoo, J., Han, H., Ma, X., Gao, W., Wu, S. (2024) Bacterial outer membrane vesicle nanorobot. Proc. Natl. Acad. Sci. USA, 121(30), e2403460121. DOI
  127. Pérez, J.G., Gontijo, M.T.P., Brocchi, M. (2023) Salmonella enterica and outer membrane vesicles are current and future options for cancer treatment. Front. Cell Infect. Microbiol., 13, 1293351. DOI
  128. Kuerban, K., Gao, X., Zhang, H., Liu, J., Dong, M., Wu, L., Ye, R., Feng, M., Ye, L. (2020) Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer. Acta Pharm. Sin. B, 10(8), 1534-1548. DOI
  129. Youssof, A.M.E., Alanazi, F.K., Salem-Bekhit, M.M., Shakeel, F., Haq, N. (2019) Bacterial ghosts carrying 5-fluorouracil: a novel biological carrier for targeting colorectal cancer. AAPS PharmSciTech, 20(2), 48. DOI
  130. Ling, D., Jia, X., Wang, K., Yan, Q., Yuan, B., Du, L., Li, M., Jin, Y. (2024) Cancer cell membrane-coated bacterial ghosts for highly efficient paclitaxel delivery against metastatic lung cancer. Acta Pharm. Sin. B, 14(1), 365-377. DOI
  131. Zhang, X., Zhang, Y., Wang, N., Shen, Y., Chen, Q., Han, L., Hu, B. (2022) Photothermal nanoheaters-modified spores for safe and controllable antitumor therapy. Int. J. Nanomedicine, 17, 6399-6412. DOI
  132. Erdal, E., Demirbilek, M., Yeh, Y., Akbal, Ö., Ruff, L., Bozkurt, D., Cabuk, A., Senel, Y., Gumuskaya, B., Algın, O., Colak, S., Esener, S., Denkbas, E.B. (2018) A comparative study of receptor-targeted magnetosome and HSA-coated iron oxide nanoparticles as MRI contrast-enhancing agent in animal cancer model. Appl. Biochem. Biotechnol., 185, 91–113 DOI
  133. Wang, X., Wang, J-G., Geng, Y-Y., Wang, J-J., Zhang, X-M., Yang, S-S., Jiang, W., Liu, W-Q. (2018) An enhanced anti-tumor effect of apoptin-cecropin B on human hepatoma cells by using bacterial magnetic particle gene delivery system. Biochemical and Biophysical Research Communications, 496, 719e725. DOI